2023 Q2 Form 10-Q Financial Statement
#000121390023039293 Filed on May 15, 2023
Income Statement
| Concept | 2023 Q2 | 2023 Q1 | 2022 Q1 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | |
| YoY Change | |||
| Cost Of Revenue | |||
| YoY Change | |||
| Gross Profit | |||
| YoY Change | |||
| Gross Profit Margin | |||
| Selling, General & Admin | $160.0K | $92.00K | |
| YoY Change | 73.91% | -84.87% | |
| % of Gross Profit | |||
| Research & Development | $233.0K | $65.00K | |
| YoY Change | 258.46% | -63.07% | |
| % of Gross Profit | |||
| Depreciation & Amortization | $10.00K | $6.000K | |
| YoY Change | 66.67% | -104.62% | |
| % of Gross Profit | |||
| Operating Expenses | $233.0K | $157.0K | |
| YoY Change | 48.41% | -79.97% | |
| Operating Profit | -$53.00K | -$393.0K | -$157.0K |
| YoY Change | -87.38% | 150.32% | |
| Interest Expense | $77.00K | $578.0K | |
| YoY Change | -86.68% | -139.94% | |
| % of Operating Profit | |||
| Other Income/Expense, Net | -$947.0K | $77.00K | $578.0K |
| YoY Change | 264.23% | -86.68% | |
| Pretax Income | -$316.0K | $421.0K | |
| YoY Change | -175.06% | -118.87% | |
| Income Tax | |||
| % Of Pretax Income | |||
| Net Earnings | -$996.0K | -$186.0K | $421.0K |
| YoY Change | 46.47% | -144.18% | -118.87% |
| Net Earnings / Revenue | |||
| Basic Earnings Per Share | -$0.24 | -$0.04 | $0.11 |
| Diluted Earnings Per Share | -$0.24 | -$0.04 | $106.8K |
| COMMON SHARES | |||
| Basic Shares Outstanding | 4.216M shares | 4.216M shares | 4.194M shares |
| Diluted Shares Outstanding | 4.216M shares | 4.216M shares | 4.194M shares |
Balance Sheet
| Concept | 2023 Q2 | 2023 Q1 | 2022 Q1 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $1.400M | $353.0K | |
| YoY Change | 296.6% | -80.4% | |
| Cash & Equivalents | $642.0K | $1.400M | $353.0K |
| Short-Term Investments | |||
| Other Short-Term Assets | $49.00K | $75.00K | $211.0K |
| YoY Change | -54.21% | -64.45% | 210.29% |
| Inventory | |||
| Prepaid Expenses | |||
| Receivables | |||
| Other Receivables | |||
| Total Short-Term Assets | $1.492M | $1.481M | $564.0K |
| YoY Change | 473.85% | 162.59% | -69.82% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $247.0K | $239.0K | $223.0K |
| YoY Change | 15.42% | 7.17% | 3085.71% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | |||
| YoY Change | |||
| Total Long-Term Assets | $269.0K | $265.0K | $223.0K |
| YoY Change | 6.75% | 18.83% | 3085.71% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $1.492M | $1.481M | $564.0K |
| Total Long-Term Assets | $269.0K | $265.0K | $223.0K |
| Total Assets | $1.761M | $1.746M | $787.0K |
| YoY Change | 243.95% | 121.86% | -58.05% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $36.00K | $42.00K | $29.00K |
| YoY Change | -21.74% | 44.83% | 2800.0% |
| Accrued Expenses | $30.00K | $20.00K | |
| YoY Change | 50.0% | ||
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $1.952M | $1.289M | |
| YoY Change | 51.44% | -18.52% | |
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $3.283M | $2.736M | |
| YoY Change | 19.99% | 16.97% | |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | |
| YoY Change | -100.0% | ||
| Other Long-Term Liabilities | $26.00K | ||
| YoY Change | -98.09% | ||
| Total Long-Term Liabilities | $0.00 | $26.00K | |
| YoY Change | -100.0% | -98.24% | |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $3.283M | $2.736M | |
| Total Long-Term Liabilities | $0.00 | $26.00K | |
| Total Liabilities | $4.251M | $3.283M | $2.828M |
| YoY Change | 41.46% | 16.09% | -30.46% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$23.79M | -$22.79M | |
| YoY Change | 11.98% | ||
| Common Stock | $4.000K | $4.000K | |
| YoY Change | 0.0% | ||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | -$3.157M | -$2.203M | -$2.041M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $1.761M | $1.746M | $787.0K |
| YoY Change | 243.95% | 121.86% | -58.05% |
Cashflow Statement
| Concept | 2023 Q2 | 2023 Q1 | 2022 Q1 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$996.0K | -$186.0K | $421.0K |
| YoY Change | 46.47% | -144.18% | -118.87% |
| Depreciation, Depletion And Amortization | $10.00K | $6.000K | |
| YoY Change | 66.67% | -104.62% | |
| Cash From Operating Activities | -$417.0K | -$260.0K | |
| YoY Change | 60.38% | -104.73% | |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $26.00K | -$177.0K | |
| YoY Change | -114.69% | -427.78% | |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | |||
| YoY Change | |||
| Cash From Investing Activities | -$26.00K | -$177.0K | |
| YoY Change | -85.31% | -427.78% | |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | $1.033M | -83.00K | |
| YoY Change | -1344.58% | -97.56% | |
| NET CHANGE | |||
| Cash From Operating Activities | -$417.0K | -260.0K | |
| Cash From Investing Activities | -$26.00K | -177.0K | |
| Cash From Financing Activities | $1.033M | -83.00K | |
| Net Change In Cash | $590.0K | -520.0K | |
| YoY Change | -213.46% | -124.15% | |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$417.0K | -$260.0K | |
| Capital Expenditures | $26.00K | -$177.0K | |
| Free Cash Flow | -$443.0K | -$83.00K | |
| YoY Change | 433.73% | -101.52% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2023Q1 | us-gaap |
Assets
Assets
|
1746000 | usd |
| CY2022Q4 | us-gaap |
Assets
Assets
|
1150000 | usd |
| CY2023Q1 | dei |
Document Type
DocumentType
|
10-Q | |
| CY2023Q1 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
| CY2023Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-03-31 | |
| CY2023Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | |
| CY2023Q1 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
| CY2023Q1 | dei |
Entity File Number
EntityFileNumber
|
333-208814 | |
| CY2023Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
SATIVUS TECH CORP. | |
| CY2023Q1 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | |
| CY2023Q1 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
47-2847446 | |
| CY2023Q1 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
#3 Bethesda Metro Center | |
| CY2023Q1 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
#700 | |
| CY2023Q1 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Bethesda | |
| CY2023Q1 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
06880 | |
| CY2023Q1 | dei |
City Area Code
CityAreaCode
|
800 | |
| CY2023Q1 | dei |
Local Phone Number
LocalPhoneNumber
|
608-6432 | |
| CY2023Q1 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
| CY2023Q1 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
No | |
| CY2023Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
| CY2023Q1 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
| CY2023Q1 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
| CY2023Q1 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | |
| CY2023Q1 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
| CY2023Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
4215571 | shares |
| CY2023Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1400000 | usd |
| CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
810000 | usd |
| CY2023Q1 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
6000 | usd |
| CY2022Q4 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
6000 | usd |
| CY2023Q1 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
75000 | usd |
| CY2022Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
85000 | usd |
| CY2023Q1 | us-gaap |
Assets Current
AssetsCurrent
|
1481000 | usd |
| CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
901000 | usd |
| CY2023Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
26000 | usd |
| CY2022Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
30000 | usd |
| CY2023Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
239000 | usd |
| CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
219000 | usd |
| CY2023Q1 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
265000 | usd |
| CY2022Q4 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
249000 | usd |
| CY2023Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
42000 | usd |
| CY2022Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
55000 | usd |
| CY2022Q4 | us-gaap |
Loans Payable Current
LoansPayableCurrent
|
114000 | usd |
| CY2023Q1 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
74000 | usd |
| CY2022Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
160000 | usd |
| CY2023Q1 | us-gaap |
Convertible Debt Current
ConvertibleDebtCurrent
|
1952000 | usd |
| CY2022Q4 | us-gaap |
Convertible Debt Current
ConvertibleDebtCurrent
|
2031000 | usd |
| CY2023Q1 | satt |
Fair Value Of Convertible Component In Convertible Loan
FairValueOfConvertibleComponentInConvertibleLoan
|
1185000 | usd |
| CY2022Q4 | satt |
Fair Value Of Convertible Component In Convertible Loan
FairValueOfConvertibleComponentInConvertibleLoan
|
1327000 | usd |
| CY2023Q1 | us-gaap |
Other Short Term Borrowings
OtherShortTermBorrowings
|
30000 | usd |
| CY2022Q4 | us-gaap |
Other Short Term Borrowings
OtherShortTermBorrowings
|
32000 | usd |
| CY2023Q1 | us-gaap |
Liabilities
Liabilities
|
3283000 | usd |
| CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
3719000 | usd |
| CY2023Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2023Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | shares |
| CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | shares |
| CY2023Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
4215571 | shares |
| CY2023Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
4215571 | shares |
| CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
4215571 | shares |
| CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
4215571 | shares |
| CY2023Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
4000 | usd |
| CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
4000 | usd |
| CY2023Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
20583000 | usd |
| CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
19756000 | usd |
| CY2023Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-22790000 | usd |
| CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-22604000 | usd |
| CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-2203000 | usd |
| CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-2844000 | usd |
| CY2023Q1 | us-gaap |
Minority Interest
MinorityInterest
|
666000 | usd |
| CY2022Q4 | us-gaap |
Minority Interest
MinorityInterest
|
275000 | usd |
| CY2023Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-1537000 | usd |
| CY2022Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-2569000 | usd |
| CY2023Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1746000 | usd |
| CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1150000 | usd |
| CY2023Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
233000 | usd |
| CY2022Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
65000 | usd |
| CY2023Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
160000 | usd |
| CY2022Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
92000 | usd |
| CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-393000 | usd |
| CY2022Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-157000 | usd |
| CY2023Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
77000 | usd |
| CY2022Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
578000 | usd |
| CY2023Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-316000 | usd |
| CY2022Q1 | us-gaap |
Profit Loss
ProfitLoss
|
421000 | usd |
| CY2023Q1 | satt |
Noncontrolling Interests
NoncontrollingInterests
|
-130000 | usd |
| CY2022Q1 | satt |
Noncontrolling Interests
NoncontrollingInterests
|
-27000 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-186000 | usd |
| CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
448000 | usd |
| CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.04 | |
| CY2022Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.11 | |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4215571 | shares |
| CY2022Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4194385 | shares |
| CY2021Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-2372000 | usd |
| CY2022Q1 | satt |
Share Based Compensation To Employees And Nonemployee
ShareBasedCompensationToEmployeesAndNonemployee
|
147000 | usd |
| CY2022Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
40000 | usd |
| CY2022Q1 | us-gaap |
Stock Granted During Period Value Sharebased Compensation Forfeited
StockGrantedDuringPeriodValueSharebasedCompensationForfeited
|
211000 | usd |
| CY2022Q1 | us-gaap |
Profit Loss
ProfitLoss
|
421000 | usd |
| CY2022Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-1975000 | usd |
| CY2022Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-2569000 | usd |
| CY2023Q1 | satt |
Share Based Compensation To Employees And Nonemployee
ShareBasedCompensationToEmployeesAndNonemployee
|
39000 | usd |
| CY2023Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
35000 | usd |
| CY2023Q1 | satt |
Stock Issued During Period Value Transactions With Noncontrolling Parties
StockIssuedDuringPeriodValueTransactionsWithNoncontrollingParties
|
1274000 | usd |
| CY2023Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-316000 | usd |
| CY2023Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-1537000 | usd |
| CY2023Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-316000 | usd |
| CY2022Q1 | us-gaap |
Profit Loss
ProfitLoss
|
421000 | usd |
| CY2023Q1 | us-gaap |
Depreciation
Depreciation
|
10000 | usd |
| CY2022Q1 | us-gaap |
Depreciation
Depreciation
|
6000 | usd |
| CY2023Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
74000 | usd |
| CY2022Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
-24000 | usd |
| CY2023Q1 | satt |
Financial Expenses Related To Loans From Related Party
FinancialExpensesRelatedToLoansFromRelatedParty
|
45000 | usd |
| CY2022Q1 | satt |
Financial Expenses Related To Loans From Related Party
FinancialExpensesRelatedToLoansFromRelatedParty
|
-1625000 | usd |
| CY2023Q1 | satt |
Change In Fair Value Of Convertible Component In Convertible Loan
ChangeInFairValueOfConvertibleComponentInConvertibleLoan
|
-141000 | usd |
| CY2022Q1 | satt |
Change In Fair Value Of Convertible Component In Convertible Loan
ChangeInFairValueOfConvertibleComponentInConvertibleLoan
|
1034000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
-10000 | usd |
| CY2022Q1 | us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
121000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
-13000 | usd |
| CY2022Q1 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
17000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
|
-86000 | usd |
| CY2022Q1 | us-gaap |
Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
|
32000 | usd |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-417000 | usd |
| CY2022Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-260000 | usd |
| CY2023Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
26000 | usd |
| CY2022Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
177000 | usd |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-26000 | usd |
| CY2022Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-177000 | usd |
| CY2023Q1 | us-gaap |
Repayments Of Debt
RepaymentsOfDebt
|
114000 | usd |
| CY2023Q1 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
5000 | usd |
| CY2022Q1 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
8000 | usd |
| CY2023Q1 | us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
121000 | usd |
| CY2022Q1 | us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
75000 | usd |
| CY2023Q1 | us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
1273000 | usd |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1033000 | usd |
| CY2022Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-83000 | usd |
| CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
590000 | usd |
| CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-520000 | usd |
| CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
810000 | usd |
| CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
886000 | usd |
| CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1400000 | usd |
| CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
366000 | usd |
| CY2023Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
121000 | usd |
| CY2022Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
75000 | usd |
| CY2023Q1 | satt |
Retained Earning Accumulated Deficit
RetainedEarningAccumulatedDeficit
|
22790000 | usd |
| CY2023Q1 | satt |
Operating Cash Flow
OperatingCashFlow
|
417000 | usd |
| CY2023Q1 | us-gaap |
Federal Home Loan Bank Borrowings Fair Value Disclosure
FederalHomeLoanBankBorrowingsFairValueDisclosure
|
1185000 | usd |
| CY2023Q1 | us-gaap |
Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
|
1185000 | usd |
| CY2022Q4 | us-gaap |
Federal Home Loan Bank Borrowings Fair Value Disclosure
FederalHomeLoanBankBorrowingsFairValueDisclosure
|
1327000 | usd |
| CY2022Q4 | us-gaap |
Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
|
1327000 | usd |
| CY2019Q1 | us-gaap |
Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
|
550 | usd |
| CY2019Q1 | us-gaap |
Derivative Fixed Interest Rate
DerivativeFixedInterestRate
|
0.10 | pure |
| CY2022 | us-gaap |
Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
|
326000 | usd |
| CY2021Q2 | satt |
Accrued Interest
AccruedInterest
|
60000 | usd |
| CY2021Q2 | satt |
Loan Amount
LoanAmount
|
14000 | usd |
| CY2022Q1 | satt |
Loan Amount
LoanAmount
|
20000 | usd |
| CY2020Q3 | satt |
Loan Payable
LoanPayable
|
100000 | usd |
| CY2020Q3 | us-gaap |
Debt Instrument Maturity Date
DebtInstrumentMaturityDate
|
2022-07-31 | |
| CY2020Q3 | us-gaap |
Debt Conversion Original Debt Interest Rate Of Debt
DebtConversionOriginalDebtInterestRateOfDebt
|
0.10 | pure |
| CY2023Q1 | us-gaap |
Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
|
18000 | usd |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
129000 | usd |
| CY2023Q1 | satt |
Revalued Values Of Bcf
RevaluedValuesOfBcf
|
59000 | usd |
| CY2022 | satt |
Revalued Values Of Bcf
RevaluedValuesOfBcf
|
88000 | usd |
| CY2023Q1 | us-gaap |
Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
|
27000 | usd |
| CY2022Q1 | us-gaap |
Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
|
15000 | usd |
| CY2023Q1 | us-gaap |
Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
|
116000 | usd |
| CY2023Q1 | us-gaap |
Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
|
116000 | usd |
| CY2023Q1 | us-gaap |
Related Party Deposit Liabilities
RelatedPartyDepositLiabilities
|
108000 | usd |
| CY2022Q1 | us-gaap |
Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
|
63000 | usd |
| CY2022Q1 | us-gaap |
Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
|
63000 | usd |
| CY2022Q1 | us-gaap |
Related Party Deposit Liabilities
RelatedPartyDepositLiabilities
|
125000 | usd |
| CY2022 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
1 | |
| CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
240000 | shares |
| CY2023Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | shares |
| CY2023Q1 | satt |
Common Stock Shares Issued And Outstanding
CommonStockSharesIssuedAndOutstanding
|
4215571 | shares |
| CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | shares |
| CY2022Q4 | satt |
Common Stock Shares Issued And Outstanding
CommonStockSharesIssuedAndOutstanding
|
4215571 | shares |
| CY2023Q1 | satt |
Schedule Of Warrant Activity
ScheduleOfWarrantActivity
|
<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Average<br/> exercise<br/> price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 76%">Warrants outstanding at January 1, 2022</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">198,750</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5.40</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.25in">Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-53">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-54">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in">Exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-55">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-56">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.25in">Forfeited/Cancelled</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(13,750</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.00</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in">Forfeited/Cancelled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(66,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1.50</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in">Warrants outstanding at December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">119,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">5.88</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in">Expired</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-57">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-58">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.25in">Exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-59">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-60">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in">Forfeited/Cancelled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-61">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-62">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in">Warrants outstanding at March 31, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">119,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5.88</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"> </p> | |
| CY2021Q4 | satt |
Number Of Warrant Outstanding
NumberOfWarrantOutstanding
|
198750 | shares |
| CY2021Q4 | satt |
Average Exercise Price Warrant Outstanding
AverageExercisePriceWarrantOutstanding
|
5.4 | |
| CY2022 | satt |
Number Warrant Forfeited Cancelled
NumberWarrantForfeitedCancelled
|
-13750 | shares |
| CY2022 | satt |
Average Exercise Price Forfeited Cancelled
AverageExercisePriceForfeitedCancelled
|
2 | |
| CY2022 | satt |
Number Warrants Forfeited Cancelled
NumberWarrantsForfeitedCancelled
|
-66000 | shares |
| CY2022 | satt |
Average Exercise Prices Forfeited Cancelled
AverageExercisePricesForfeitedCancelled
|
1.5 | |
| CY2022Q4 | satt |
Number Of Warrant Outstanding
NumberOfWarrantOutstanding
|
119000 | shares |
| CY2022Q4 | satt |
Average Exercise Price Warrant Outstanding
AverageExercisePriceWarrantOutstanding
|
5.88 | |
| CY2023Q1 | satt |
Number Of Warrant Outstanding
NumberOfWarrantOutstanding
|
119000 | shares |
| CY2023Q1 | satt |
Average Exercise Price Warrant Outstanding
AverageExercisePriceWarrantOutstanding
|
5.88 | |
| CY2022Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
119000 | shares |
| CY2022 | satt |
Class Of Warrant Or Righst Warrants Or Rights Exercisable
ClassOfWarrantOrRighstWarrantsOrRightsExercisable
|
119000 | shares |
| CY2023Q1 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
119000 | shares |
| CY2023Q1 | satt |
Class Of Warrant Or Righst Warrants Or Rights Exercisable
ClassOfWarrantOrRighstWarrantsOrRightsExercisable
|
119000 | shares |
| CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
195000 | shares |
| CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.63 | |
| CY2022 | satt |
Shares Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
45000 | shares |
| CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.7 | |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
240000 | shares |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.7 | |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
215000 | shares |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
0.72 | |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
240000 | shares |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
215000 | shares |
| CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
196000 | shares |
| CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
370000 | shares |
| CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
|
30000 | shares |
| CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
536000 | shares |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
536000 | shares |
| CY2023Q1 | satt |
Financial Expenses Related To Interest And Revaluation
FinancialExpensesRelatedToInterestAndRevaluation
|
-80000 | usd |
| CY2022Q1 | satt |
Financial Expenses Related To Interest And Revaluation
FinancialExpensesRelatedToInterestAndRevaluation
|
-596000 | usd |
| CY2023Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
|
-3000 | usd |
| CY2022Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
|
-18000 | usd |
| CY2023Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
77000 | usd |
| CY2022Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
578000 | usd |
| CY2022 | satt |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised
|
shares | |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
shares | |
| CY2023Q1 | satt |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised
|
shares | |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
|
shares | |
| CY2023Q1 | satt |
Expenses Due To Change In Fair Value Of Warrant
ExpensesDueToChangeInFairValueOfWarrant
|
usd | |
| CY2022Q1 | satt |
Expenses Due To Change In Fair Value Of Warrant
ExpensesDueToChangeInFairValueOfWarrant
|
usd | |
| CY2023Q1 | us-gaap |
Investment Maturity Date
InvestmentMaturityDate
|
2024-09-11 | |
| CY2023Q1 | us-gaap |
Facility Costs
FacilityCosts
|
2000 | usd |
| CY2023Q1 | us-gaap |
Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
|
23000 | usd |
| CY2023Q1 | us-gaap |
Sale Of Stock Description Of Transaction
SaleOfStockDescriptionOfTransaction
|
In the first 3 years of sales the Company shall pay 3% of the sales of the product which was developed under IIA research and development projects. In the fourth, fifth and sixth years of sales, the Company shall pay 4% of such sales and from the seventh year onwards the Company shall pay 5% of up to 100% of the amount of grants received plus interest at LIBOR. | |
| CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.04 | |
| CY2022Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.11 | |
| CY2022Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
4194385 | shares |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
4215571 | shares |
| CY2022Q1 | us-gaap |
Repayments Of Debt
RepaymentsOfDebt
|
usd | |
| CY2022Q1 | us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
usd | |
| CY2023Q1 | us-gaap |
Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
|
usd | |
| CY2023Q1 | us-gaap |
Employee Service Share Based Compensation Cash Flow Effect Cash Used To Settle Awards
EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards
|
usd | |
| CY2022Q1 | us-gaap |
Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
|
usd | |
| CY2022 | satt |
Number Warrant Granted
NumberWarrantGranted
|
shares | |
| CY2022 | satt |
Average Exercise Price Warrants Granted
AverageExercisePriceWarrantsGranted
|
||
| CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
|
shares | |
| CY2022 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
||
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
shares | |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
||
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
|
shares | |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
||
| CY2023Q1 | satt |
Number Warrants Forfeited Cancelled
NumberWarrantsForfeitedCancelled
|
shares | |
| CY2023Q1 | satt |
Average Exercise Prices Forfeited Cancelled
AverageExercisePricesForfeitedCancelled
|
||
| CY2022 | satt |
Number Options Exercised
NumberOptionsExercised
|
shares | |
| CY2022 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
||
| CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
shares | |
| CY2022 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
||
| CY2023Q1 | satt |
Shares Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
shares | |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
||
| CY2023Q1 | satt |
Number Options Exercised
NumberOptionsExercised
|
shares | |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
||
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
shares | |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
||
| CY2023Q1 | us-gaap |
Future Minimum Sublease Rentals Sale Leaseback Transactions
FutureMinimumSubleaseRentalsSaleLeasebackTransactions
|
usd | |
| CY2023Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2023Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
| CY2023Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
| CY2023Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001661600 |
